These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228 [TBL] [Abstract][Full Text] [Related]
4. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596 [TBL] [Abstract][Full Text] [Related]
5. Negative metabolic and coronary flow effects of decreases in cAMP and increases in cGMP in control and renal hypertensive rabbit hearts. Rodriguez R; Molino B; Weiss HR; Scholz PM J Appl Physiol (1985); 2004 Jul; 97(1):439-45. PubMed ID: 14990553 [TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts. Leone RJ; Straznicka M; Scholz PM; Weiss HR Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543 [TBL] [Abstract][Full Text] [Related]
7. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts. Leone RJ; Weiss HR; Scholz PM J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527 [TBL] [Abstract][Full Text] [Related]
8. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes. Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266 [TBL] [Abstract][Full Text] [Related]
9. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts. Naim KL; Rabindranauth P; Weiss HR; Tse J; Leone RJ; Scholz PM Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398 [TBL] [Abstract][Full Text] [Related]
10. Action of acetylcholine on regional myocardial work and metabolism in vivo: association with cyclic GMP. Guo X; Kedem J; Scholz PM; Weiss HR Can J Physiol Pharmacol; 1996 Jan; 74(1):73-9. PubMed ID: 8963954 [TBL] [Abstract][Full Text] [Related]
11. Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators. Kobayashi A; Ogawa K Jpn Circ J; 1979 Dec; 43 Suppl 1():6-8, 46-54. PubMed ID: 230369 [TBL] [Abstract][Full Text] [Related]
12. Effect of isoproterenol on coronary blood flow and signal transduction responses in thyroxine-treated rabbit hearts. Rodriguez E; Weiss HR; Gonzalez M; Tse J J Mol Cell Cardiol; 1993 Aug; 25(8):939-47. PubMed ID: 8263963 [TBL] [Abstract][Full Text] [Related]
13. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes. Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530 [TBL] [Abstract][Full Text] [Related]
14. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy. Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695 [TBL] [Abstract][Full Text] [Related]